{
  "claim_id": "test_streamlined_001",
  "claim": "Flublok contains 45 micrograms (mcg) of HA per strain vs 15 mcg of HA per strain in a standard-dose influenza vaccine.",
  "document": "FlublokPI",
  "verification_stats": {
    "total_extracted": 3,
    "verified": 1,
    "rejected": 2,
    "verification_rate": 0.3333333333333333
  },
  "verified_evidence": [
    {
      "id": 1,
      "quote": "For the 2024-2025 influenza season it is formulated to contain 135 mcg HA per 0.5 mL dose, with 45 mcg HA of each of the following 3 influenza virus strains: A/West Virginia 30 2022 (A/Wisconsin/67/2022 pdm 09 like virus) (H1 N1), A/Massachusetts/18/ 2022 (H3 N2) and B/Austria/1359417/2021.",
      "supports_claim": true,
      "explanation": "This quote directly states that Flublok contains 45 mcg of HA per strain for each of the three influenza virus strains, which matches the claim exactly and provides the specific numbers needed to substantiate it.",
      "original_relevance": "This quote directly states that Flublok contains 45 mcg of HA per strain (for three strains, totaling 135 mcg per dose), supporting the claim about Flublok's HA content."
    }
  ],
  "rejected_evidence": [
    {
      "id": 2,
      "quote": "Across three clinical trials (Studies 2 \u2013 4, Tables 2 and 3) a total of 2050 adults age 50 years and older received Flublok and 2048 received a U.S.-licensed trivalent in activated influenza vaccine (IIV3) comparator.",
      "reason": "Too tangential \u2013 does not address or provide evidence for the specific HA content per strain in Flublok or standard-dose vaccines.",
      "original_explanation": "This quote establishes that the comparator is a standard-dose influenza vaccine, which is relevant for comparing the HA content per strain between Flublok and standard-dose vaccines."
    },
    {
      "id": 3,
      "quote": "Data froma randomized, controlled trial demonstrated that children 6 months to less than 3 years of age had diminished hemagglutinin inhibition (HI) responses to Flublok compared to au. S.-licensedinfluenza vaccine approved for usein this population, strongly suggesting that Flublok would not be effective in children younger than3 years of age (6).",
      "reason": "Too tangential \u2013 the quote is about immunogenicity in a specific age group, not about the HA content per strain.",
      "original_explanation": "This quote references a comparison between Flublok and a standard U.S.-licensed influenza vaccine, which is relevant context for the claim about differences in HA content per strain."
    }
  ],
  "model_used": "gpt-4.1"
}